Brian MacDonald
Plus aucun poste en cours
Fortune : 412 757 $ au 30/04/2024
Profil
Brian MacDonald is the founder of Disc Medicine Opco, Inc. He previously worked as the Chief Innovation Officer at Disc Medicine, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
DISC MEDICINE, INC.
0,06% | 30/06/2023 | 15 564 ( 0,06% ) | 412 757 $ | 30/04/2024 |
Anciens postes connus de Brian MacDonald
| Sociétés | Poste | Fin |
|---|---|---|
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Directeur Général | 25/02/2020 |
| DISC MEDICINE, INC. | Directeur Technique/Scientifique/R&D | 20/12/2023 |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DISC MEDICINE, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Health Technology |